Laboratory diagnosis of thrombophilic states: Where do we stand?

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 5-6, 2002, Pages 245-248

  Tripodi, Armando ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE   (Italy)

Author keywords

Laboratory investigation; Thrombophilia; Thrombosis

Indexed keywords

ANTITHROMBIN; APC; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTITHROMBIN DEFICIENCY; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; HUMAN; LABORATORY TEST; MUTATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; HEMATOLOGY; LABORATORY; REVIEW;

HEMATOLOGY; HUMANS; LABORATORIES; THROMBOPHILIA;

EID: 0142135580     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073574     Document Type: Conference Paper

References (12)

1. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. The Lancet 1995; 345: 152-55.
2. Van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor FIX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.
3. Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendaal FR. High levels of factor FXI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
4. Van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk of deep vein thrombosis. Blood 2000; 95: 2855-9.
5. Greaves M, Baglin T. Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease. Brit J Haematol 2000; 109: 699-703.
6. Mannucci PM. Genetic hypercoagulability: prevention suggests testing family members. Blood 2001; 98: 21-22.
7. Vandenbroucke JP, van der Meer FJM, Helmerhorst FM, Rosendaal FR. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Brit Med J 1996; 313: 1127-30.
8. Demers C, Henderson P, Blajchman MA, Wells MJ, Mitchell L, Johnston M, et al. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition. Thromb Haemost 1993; 69: 231-5.
9. Simmonds RE, Ireland H, Lane DA, Zoller B, Garcia de Frutos P, Dahlback B. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med 1998; 128: 8-14.
10. de Visser MCH, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis Blood 1999; 93: 1271-6.
11. Tripodi A, Chantarangkul V, Lombardi R, Lecchi A, Mannucci PM, Cattaneo M. Multicenter study of homocysteine measurement. Performance characteristics of different methods, influence of standards on interlaboratory agreement of results. Thromb Haemost 2001; 85: 291-5.
12. Brandt JT, Triplett DA, Alving B, Scharrer IM. Criteria for the diagnosis of lupus anticoagulants: an update [Review]. Thromb Haemost 1995; 74; 1185-90.